10 results about "Newborn infant" patented technology

Provided herein is a system for dynamic assessment of a prediction of late onset sepsis, LOS, in a test neonatal subject, a test subject, the system comprising a processor configured to perform steps of a method comprising: - receiving a parameter time series (120,a to i) of a measurement of at least one parameter, a test parameter, measured of the test subject after birth of the test subject during a test session; - determining a prediction time series (130a to g) of sequential prediction scores for LOS, TLOSPS(ptd), of the test subject, wherein - each TLOSPS(ptd) within the prediction time series is determined at a determination time point, ptd; - each TLOSPS(ptd) (e.g. 130,a or 130,e) is determined from the at least one parameter time series (e.g. 120,a or 120,a) limited to a parameter time window, PTW, - the PTW spans up to the ptd, and extends back in time according to a size of the PTW; - dynamically evaluating the TLOSPS(ptd), by comparing the TLOSPS(ptd) against a dynamically-adjusted threshold score, THS(ptd).

An adhesive skin dressing kit for securing a medical device to a newborn infant includes a pair of storage sheets each comprised of an adhesive resistant material. A plurality of first adhesive pads is each removably adhered to the adhesive resistant material of a respective one of the pair of storage sheets. A plurality of second adhesive pads is each of the plurality of second adhesive pads is removably adhered to the adhesive resistant material of a respective one of the pair of storage sheets. Each of the plurality of second adhesive pads and first adhesive pads has dimensions sufficiently small to enable the each of the plurality of second adhesive pads to be positionable over a respective one of the plurality of first adhesive pads on the newborn infant's face for securing a medical device between the first adhesive pad and the second adhesive pad.

The invention discloses a head deviation preventing device for neonatal care, and relates to the technical field of neonatal care. A first protection pad is laid on the inner side of the supporting frame, a fixing plate is fixed to the rear side of the top of the first protection pad, a second protection pad is arranged on the first protection pad, a head latex pad is arranged at the top of the fixing plate, the head latex pad is arranged in the center of the second protection pad, and two supporting assemblies are oppositely arranged at the top of the fixing plate. The supporting assembly is arranged on the inner side of the second protection pad, the two sides of the second protection pad can be conveniently supported, the supporting assembly and the head latex pad form a U-shaped structure, the head of a newborn infant can be conveniently placed, a self-adaptive adjusting assembly is arranged on one side of the supporting assembly, an attraction assembly is fixed to the rear side of the supporting frame, and under mutual cooperation of the self-adaptive adjusting assembly and the attraction assembly, the head of the newborn infant can be attracted. The condition that the head of the newborn baby deviates can be conveniently monitored in real time, self-adaptive adjustment is carried out, and the using effect of the device is effectively improved.

In this invention, the inventors report the characterization of BCLA (brain cyst-loaded antigen), a protein uniquely expressed in the merozoite stage of a parasite. In cysts directly purified from mouse brain, the protein is distributed both internally and on the surface of the cyst. ELISA antibody capture using a combination of serologically reactive BCLA peptide and recombinantly expressed C-terminal domain (rBCLA) constitutes an effective serological marker of latent infection with high sensitivity, definitively and uniquely correlated with the presence of cysts in mouse brain. Antibodies against the BCLA antigen have been detected in human patients. Enrichment titers were detected in patients identified as seropositive for Sag1 or tachyzoite-associated antigen. Further correlation between anti-BCLA IgG synthesis and cysts in humans was demonstrated by significantly stronger recorded titers in the pathology group strongly correlated with the presence of cysts. Furthermore, newborns with confirmed congenital toxoplasmosis showed significantly higher levels of anti-BCLA IgG at birth compared to their mothers, indicating specific intrauterine synthesis of this IgG. Therefore, this invention relates to a novel Toxoplasma gondii protein, hereinafter referred to as BCLA, which is a novel serological marker whose expression is limited to latent toxoplasmosis (schizonts / cysts). This specific protein and its antigenic fragments can be used to detect autoantibodies in patient serum for the diagnosis of latent toxoplasmosis. This invention also relates to derived antibodies that specifically bind to this novel protein, generated through immunization with BCLA.

The present invention relates to a device designed to safely and securely hold newborn infants during radiographic imaging and medical procedures. This device aims to immobilize neonates to prevent motion artifact during imaging while also protecting healthcare professionals from unnecessary radiation exposure, offering a safer alternative for conducting radiographic imaging on newborns and pediatric population. The device may be constructed primarily of fiberglass, or any medically graded radiolucent materials providing a lightweight, durable, and radiolucent structure. It can be padded with a soft cushion and incorporates a series of adjustable constraints to comfortably and securely hold the baby in place, allowing for precise positioning during radiographic imaging and medical procedures.

Nasal cannula (5) for supplying a patient with respiratory gas during high-flow therapy, wherein the patient is a premature or newborn infant, an infant or a baby, wherein the nasal cannula (5) comprises: a nasal attachment piece (13) comprising a hollow base body (15), a hose connection (9) for connecting a supply hose (7) to the base body (15) so that respiratory gas can flow from the supply hose (7) into the base body (15), and two nasal nozzles (17) extending from the base body (15) for directing the respiratory gas from the base body (15) into the nose (19) of the patient; a first cheek pad (23) for supporting and / or fixing the nasal attachment piece (13) to a first cheek of the patient; a second cheek pad (25) for supporting and / or fixing the nasal attachment piece (13) to a second cheek of the patient; a retaining strap (21) that can be stretched around the patient's head to apply additional holding force to the nasal attachment piece (13) and / or the two cheek pads (23, 25).

This utility model discloses a shock-absorbing support for a transport incubator, specifically a shock-absorbing support for placement inside a transport incubator. It includes an injection-molded mattress support and a base plate. The adjacent surfaces of the injection-molded mattress support and the base plate are symmetrically equipped with adapter seats distributed along a pair of opposite corners, with the two opposite corners being different. It also includes a buffer damping module, which, according to its structure, consists of a first hinge rod and a second hinge rod. The end face of the first hinge rod has a guide rod that is slidably fitted into a bore at the end of the second hinge rod. A first equidistant spring is fixedly installed between the first and second hinge rods, sleeved on the outside of the guide rod. The first and second hinge rods are respectively hinged to adapter seats on the same side. This utility model adds a mattress support with vertical cushioning capacity inside the incubator, thereby minimizing the impact of vibration on newborn infants.

The invention provides a jaundice treatment and protection device, relates to the technical field of biomedical engineering, and aims to solve the problems that a new-born infant is directly irradiated by a blue light lamp in a jaundice treatment process, the irradiation position is fixed and needs to be manually adjusted, the time is difficult to accurately grasp, the jaundice treatment effect is not uniform enough, and the use cost is high. The newborn baby safety protection device comprises a protection rack; two end protection plates are vertically and upwards arranged on the top plane of the protection rack in a bilateral symmetry manner; a cylindrical blue light irradiation cylinder is arranged between the left end protection plate and the right end protection plate; a treatment table is transversely arranged in the blue light irradiation cylinder, and the bottoms of the left end and the right end of the treatment table are fixedly connected with the top plane of the protection rack. According to the jaundice treatment table, the blue light irradiation cylinder can rotate, jaundice treatment can be conducted on a baby placed on the drawing tray in the treatment table, 360-degree rotation can be achieved, and treatment is more comprehensive.

The present invention relates to an apparatus and method for providing safe and effective access for a newborn infant, i.e. a neonate, to a neonatal warming device while the umbilical cord is still intact. The apparatus comprises a stable support extension tray that enables movement of the mattress and the warmed surface of the warming device to allow for delayed cord clamping (DCC) of an umbilical cord attached to the infant and mother, while also providing full access to the life support features housed within the warming device, access for healthcare personnel to attend to the neonate, access for healthcare personnel to attend to the mother while maintaining sterile conditions for the mother in the case of a C-section (Caesarean section) delivery.